Literature DB >> 20047611

Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients.

Shao Hua Shi1, Hai Shen Kong, Chang Ku Jia, Wen Jin Zhang, Jian Xu, Wei Lin Wang, Yan Shen, Min Zhang, Shu Sen Zheng.   

Abstract

Pneumonia caused by multidrug-resistant (MDR) Gram-negative bacilli is associated with a higher mortality rate. The appropriate empiric therapy is based on the understanding of local etiology and MDR pattern. This study was to evaluate the spectrum of Gram-negative bacilli, MDR rate, risk factors and mortality in 475 liver transplantation (LT) recipients. In the first six months after LT, the incidence of bacterial pneumonia was 21.3% (101/475). The overall infectious incidence during the first post-transplant month was 80.2%. The most frequent pneumonia isolates were Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus. Gram-negative bacilli accounted for 69.6% of all pneumonia pathogens. Of the main 124 Gram-negative bacilli isolates, MDR rate was 58.9%. Four risk factors for post-LT pneumonia caused by MDR Gram-negative bacilli were LT candidates with grade II-IV encephalopathy (OR 2.275, 95%CI 1.249-4.124, p = 0.006), prolonged duration of endotracheal intubation (OR 8.224, 95%CI 4.276-15.815, p = 0.013), tracheostomy (OR 4.929, 95%CI 1.099-18.308, p = 0.027) and post-LT episode(s) of reoperations (OR 10.597, 95%CI 3.726-30.134, p < 0.001). MDR Gram-negative bacterial pneumonia-related mortality was significantly higher than that because of antibiotic-susceptible bacilli (45.6% vs. 11.4%, p = 0.010). Our data suggest that pneumonia caused by MDR Gram-negative bacilli after LT is common, and associated with the severity of underlying disease, prolonged mechanical ventilation and upper abdominal surgery.
© 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20047611     DOI: 10.1111/j.1399-0012.2009.01184.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  10 in total

1.  Multidrug-resistant bacteria in organ transplantation: an emerging threat with limited therapeutic options.

Authors:  Gopi Patel; Meenakshi M Rana; Shirish Huprikar
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

2.  Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

Authors:  B Saugel; K Eschermann; R Hoffmann; A Hapfelmeier; C Schultheiss; V Phillip; F Eyer; K-L Laugwitz; R M Schmid; W Huber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-07       Impact factor: 3.267

Review 3.  Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.

Authors:  Gang Chen; Kailiang Xu; Fangyuan Sun; Yuxia Sun; Ziyuan Kong; Bangjiang Fang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-06-30       Impact factor: 2.471

4.  Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma.

Authors:  Kai Nie; Rongzheng Ran; Weifeng Tan; Bin Yi; Xiangji Luo; Yong Yu; Xiaoqing Jiang
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

Review 5.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  [Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant].

Authors:  Asunción Moreno Camacho; Isabel Ruiz Camps
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-06-18       Impact factor: 1.731

7.  Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.

Authors:  Philip G Ferstl; Natalie Filmann; Eva-Maria Heilgenthal; Andreas A Schnitzbauer; Wolf O Bechstein; Volkhard A J Kempf; David Villinger; Tilman G Schultze; Michael Hogardt; Christoph Stephan; Haitham Mutlak; Nina Weiler; Marcus M Mücke; Jonel Trebicka; Stefan Zeuzem; Oliver Waidmann; Martin-Walter Welker
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

8.  Treatment of multidrug-resistant gram-negative bacilli after solid organ transplant: Outcomes and complications.

Authors:  Madeleine R Heldman; Kexin Guo; Brett Nelson; Tenzin Babu; Michael G Ison
Journal:  Transpl Infect Dis       Date:  2020-10-07

9.  Epidemiological Analysis of Extended-Spectrum Beta-Lactamase-Producing Bacterial Infections in Adult Live Donor Liver Transplant Patients.

Authors:  Ajeet Singh; Deepak Govil; Usha Krishan Baveja; Anand Gupta; Neha Tandon; Shrikanth Srinivasan; Sachin Gupta; Sweta J Patel; Sanjiv Saigal; Arvinder Singh Soin
Journal:  Indian J Crit Care Med       Date:  2018-04

Review 10.  Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.

Authors:  Elda Righi
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.